about
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationOverweight, obesity, and elevated serum cystatin C levels in adults in the United StatesBasic science: Pathophysiology: the cardiorenal metabolic syndromeManagement of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapyThe living kidney donor evaluation: focus on renal issuesContextual poverty, nutrition, and chronic kidney diseaseManagement of obesity-induced kidney disease: a critical review of the literatureObesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic StrategiesA low-carbohydrate diet may prevent end-stage renal failure in type 2 diabetes. A case reportBlood cadmium and lead and chronic kidney disease in US adults: a joint analysisTriglycerides in the human kidney cortex: relationship with body sizeHigh Fat High Cholesterol Diet (Western Diet) Aggravates Atherosclerosis, Hyperglycemia and Renal Failure in Nephrectomized LDL Receptor Knockout Mice: Role of Intestine Derived LipopolysaccharideCentral obesity associates with renal hyperfiltration in the non-diabetic general population: a cross-sectional studyAn association between air pollution and daily outpatient visits for respiratory disease in a heavy industry areaAnthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3Pesticide use and risk of end-stage renal disease among licensed pesticide applicators in the Agricultural Health StudyHeart disease and stroke statistics--2011 update: a report from the American Heart AssociationHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationHeart disease and stroke statistics--2012 update: a report from the American Heart AssociationObesity and Kidney Disease: Hidden Consequences of the Epidemic.Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationKidney disease and obesity: epidemiology, mechanisms and treatment.Social Determinants of Racial Disparities in CKD.Obesity-hypertension: an ongoing pandemic.Renal outcomes of bariatric surgery in obese adults with diabetic kidney disease.Challenges of treating a 466-kilogram man with acute kidney injury.Association of body mass index with outcomes in patients with CKD.The Role of Overweight and Obesity in the Cardiorenal Syndrome.A prospective study of frailty in nephrology-referred patients with CKD.Metabolic imaging of human kidney triglyceride content: reproducibility of proton magnetic resonance spectroscopy.End-stage renal disease in young black males in a black-white population: longitudinal analysis of the Bogalusa Heart Study.Sex differences in the association between obesity and albuminuria among Korean adults: a cross-sectional study using the Korea National Health and Nutrition Examination Survey data.Impact of race and gender on live kidney donation.Sugary soda consumption and albuminuria: results from the National Health and Nutrition Examination Survey, 1999-2004.End stage renal disease.Short-term renal outcomes in African American and Caucasian donors following live kidney donation.The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin.Short-term outcomes for obese live kidney donors and their recipients.Vegetarian Diet in Chronic Kidney Disease-A Friend or Foe.Estimated visceral adipose tissue, but not body mass index, is associated with reductions in glomerular filtration rate based on cystatin C in the early stages of chronic kidney disease.
P2860
Q22306356-F271CB45-3C9A-4356-9B49-EAC1909E8825Q24607254-D0FB382E-E67F-47C7-B736-A293C646D58FQ26823487-308245B6-C7DD-4F5E-B3D4-F11AF3F808C9Q26859689-A357842D-62F4-439D-AEC9-2296DBCFB135Q27000688-1EC0FD9E-2A99-449E-8BDB-B275C693BA5AQ27025550-E1BB3C99-1ABD-4D7A-AF73-9FBF22F6650AQ27027141-2833F0D8-6873-4328-AEFB-B352AE379ECCQ28088325-6CF5FEB9-2D1F-4374-8579-2E8B88FE6509Q28219083-3F573159-9C6D-455C-883F-31BFFE0E2D28Q28392186-BB0C2FB7-E913-4FF6-93CC-94ED72315834Q28542644-B8103A1F-5232-4758-940B-FE6C391B4C37Q28551030-88FFCF05-C681-4435-B666-08830DD2AB0AQ28595982-E34358A9-E6F8-4FF3-8302-590A160AA370Q28662132-C5B90C9B-B5FE-4EB4-B97D-30ABFA22F29FQ28730621-B8769820-6098-4E65-A26D-9F6485C63547Q29248563-7B297D83-4952-448D-9987-48B2B7CCD4D5Q29547236-CABE3EC6-F1F9-413A-B2BB-D8774EAB69EBQ29547691-CA3ECB23-281E-4052-8CD1-B1404C7B3536Q29547909-2EF0CD0C-8A2C-48B3-AA59-751D70E009BBQ30235506-E99E1F37-0BE5-4C2C-92B0-8FDCE90F7DDFQ30238784-1EC2B3DC-04B2-4999-82F0-2583155751C9Q30239002-B8094E6A-0176-48AD-B1D9-ADEAA971F33AQ30250319-21D692C1-05AD-48DA-8BEA-1D7FAB1B31BDQ30359525-CE542EC5-355A-4134-B94C-D5350781A3EFQ30360386-48447D54-0EF0-4838-801D-BD21621E1FC2Q30369522-20FDBAAA-7055-44FA-B140-B023F791533BQ30371128-BC279B91-AB42-44A6-A7C1-80BA151AF46FQ30411964-CB5EEB73-AD35-4451-A1CB-E720AC52E945Q30528010-1FDD3F43-D418-43CB-A391-4D998FBE3AC7Q30620037-6CC68425-C81D-451F-A90E-412B5148E6A9Q30939425-281B5E12-2221-44FA-B234-1B6B6494C141Q31048280-EB656513-0D43-4806-BFE3-ED922CB3F814Q33368836-A7DF5031-C7EA-41F2-A3BD-0C9FA53BDB4DQ33377446-D92594AD-2B6D-4E5E-AB28-C5FBD4540A06Q33446829-0AB6C3B9-E911-406D-90F8-52D03DBC7942Q33518881-D26CF4A7-8F09-4842-80E5-2425BA65BD16Q33572275-7CA06D41-D345-412D-9598-74E43C3AA2F0Q33615274-C247EB15-47D4-4B68-906B-107DE3B6902CQ33616816-6013F078-66DF-4BF8-9776-4F8ACBF4C6A1Q33634956-82E1103C-D367-4840-9AA5-B5684CC31099
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Body mass index and risk for end-stage renal disease.
@en
Body mass index and risk for end-stage renal disease.
@nl
type
label
Body mass index and risk for end-stage renal disease.
@en
Body mass index and risk for end-stage renal disease.
@nl
prefLabel
Body mass index and risk for end-stage renal disease.
@en
Body mass index and risk for end-stage renal disease.
@nl
P2093
P1476
Body mass index and risk for end-stage renal disease.
@en
P2093
Carlos Iribarren
Charles E McCulloch
Chi-yuan Hsu
Jeanne Darbinian
P356
10.7326/0003-4819-144-1-200601030-00006
P407
P577
2006-01-01T00:00:00Z